Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

Welcome to this week’s Food Exec Brief, a roundup of the most important news shaping food and beverage manufacturing, from ...

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

Neurologist Dr. Gavin Brown describes Parkinson’s disease as one of the most common neurodegenerative conditions, second only ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...

Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes ...

Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes scientists' understanding of how brain inflammation arises in Alzheimer's disease.

For many investors, getting involved with pharmaceutical stocks involves finding inexpensive stocks, often penny stocks, in ...

Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...